Cargando…
Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial
AIMS: Most cardiac surgery patients, with or without diabetes, develop perioperative hyperglycaemia, for which intravenous insulin is the only therapeutic option. This is labour‐intensive and carries a risk of hypoglycaemia. We hypothesized that preoperative administration of the glucagon‐like pepti...
Autores principales: | Hulst, Abraham H., Visscher, Maarten J., Godfried, Marc B., Thiel, Bram, Gerritse, Bastiaan M., Scohy, Thierry V., Bouwman, R. Arthur, Willemsen, Mark G. A., Hollmann, Markus W., Preckel, Benedikt, DeVries, J. Hans, Hermanides, Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079116/ https://www.ncbi.nlm.nih.gov/pubmed/31749275 http://dx.doi.org/10.1111/dom.13927 |
Ejemplares similares
-
Study protocol of the randomised placebo-controlled GLOBE trial: GLP-1 for bridging of hyperglycaemia during cardiac surgery
por: Hulst, Abraham H, et al.
Publicado: (2018) -
Effects of Liraglutide on Myocardial Function After Cardiac Surgery: A Secondary Analysis of the Randomised Controlled GLOBE Trial
por: Hulst, Abraham H., et al.
Publicado: (2020) -
Study protocol of a randomised controlled trial comparing perioperative intravenous insulin, GIK or GLP-1 treatment in diabetes–PILGRIM trial
por: Polderman, Jorinde AW, et al.
Publicado: (2014) -
Systematic review of incretin therapy during peri-operative and intensive care
por: Hulst, Abraham H, et al.
Publicado: (2018) -
Effects of Hyperglycemia and Diabetes Mellitus on Coagulation and Hemostasis
por: Li, Xiaoling, et al.
Publicado: (2021)